Pacific Biosciences Of California reported $301.96M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.7M 358K Dec/2025
Bruker USD 151.94M 225K Dec/2025
Danaher USD 706.9M 600K Dec/2025
General Electric Aerospace USD 1.05B 6.05M Dec/2025
Illumina USD 152.8M 900K Dec/2025
Myriad Genetics USD 93.5M 400K Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 67.9M 200K Sep/2025
Revvity USD 113.38M 2.7M Dec/2025
Roche Holding CHF 795.62M 699.54K Dec/2025
Standard Biotools USD 386.38M 2.77M Dec/2025
Thermo Fisher Scientific USD 375.71M 1.9M Dec/2025
Waters USD 98.08M 38.55M Dec/2025